A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: Results of the Binge Eating and Chromium (BEACh) Study
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective Chromium treatment has been shown to improve mood, appetite, and glucose regulation in various psychiatric and medical patient populations. The authors propose that chromium may be useful in the treatment of binge eating disorder (BED). Method Twenty-four overweight adults with BED were enrolled in a 6-month double-blind placebo-controlled trial and randomly assigned to receive either 1000mcg chromium/day (“high dose”; n=8) or 600mcg chromium/day (“moderate dose”; n=9) as chromium picolinate or placebo (n=7). Mixed linear regression models were used to estimate mean change in binge frequency and related psychopathology, weight, symptoms of depression, and fasting glucose. Results Fasting glucose was significantly reduced in both chromium groups compared to the placebo group; similarly, numerically, but not significantly, greater reductions in binge frequency, weight, and symptoms of depression were observed in those treated with chromium versus placebo, although statistical power was limited in this pilot trial. For fasting glucose, the findings suggest a dose response with larger effects in the high dose compared to moderate dose group. Conclusion These initial findings support further larger trials to determine chromium’s efficacy in maintaining normal glucose regulation, reducing binge eating and related psychopathology, promoting modest weight loss, and reducing symptoms of depression in individuals with BED. Studies designed to link the clinical effects of chromium with changes in underlying insulin, serotonin, and dopamine pathways may be especially informative. If efficacious, chromium supplementation may provide a useful, low-cost alternative to or augmentation strategy for selective serotonin reuptake inhibitors, which have partial efficacy in BED. ClinicalTrials.gov NCT00904306.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurobiology of anorexia and bulimia nervosa
Kaye, W. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.037 · Cited by 625 · cited 1×
“Neuroimaging studies demonstrate abnormalities in brain reward, emotion/attention, and sympathetic nervous system pathways [for review, 57] and, more specifically, in 5HT and DA activity [58–60] in individuals who binge eat.”
Binge eating disorder treatment: a systematic review of randomized controlled trials
Brownley, K. A., Berkman, N. D., Sedway, J. A., Lohr, K. N., & Bulik, C. M. (2007) · International Journal of Eating Disorders · doi:10.1002/eat.20370 · Cited by 346
Self-citationEffect of Chromium Supplementation on Glucose Metabolism and Lipids
Balk, E. M., Tatsioni, A., Lichtenstein, A. H., Lau, J., & Pittas, A. G. (2007) · Diabetes Care · doi:10.2337/dc06-0996 · Cited by 294
Reward sensitivity and the D2 dopamine receptor gene: A case-control study of binge eating disorder
Davis, C., Levitan, R. D., Kaplan, A. S., Carter, J., Reid, C., Curtis, C., Patte, K., Hwang, R., & Kennedy, J. L. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.024 · Cited by 200 · cited 1×
“Neuroimaging studies demonstrate abnormalities in brain reward, emotion/attention, and sympathetic nervous system pathways [for review, [57]] and, more specifically, in 5HT and DA activity [58-60] in individuals who binge eat.”
Sharma, S., Agrawal, R. P., Choudhary, M., Jain, S., Goyal, S., & Agarwal, V. (2011) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2011.03.003 · Cited by 120 · cited 1×
“Based on its known insulin sensitizing actions, chromium has been investigated as an alternative treatment in type-2 diabetes and other insulin-resistant conditions, but results have been mixed [20, 22, 50-54] and routine prescription of chromium for individuals with diabetes remains highly controversial [55].”
de Bartolomeis, A., Buonaguro, E. F., & Iasevoli, F. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2921-8 · Cited by 89 · cited 1×
“Chromium directly enhances insulin [11, 12] and serotonergic (5HT) [13, 14] activity and may also have downstream effects on dopaminergic (DA) signaling – all three neurotransmitters share a common protein kinase pathway involved in the central control of food intake and energy homeostasis [15-17], and 5HT and DA rece…”
Effects of Chromium Picolinate on Food Intake and Satiety
Anton, S. D., Morrison, C. D., Cefalu, W. T., Martin, C. K., Coulon, S., Geiselman, P., Han, H., White, C. L., & Williamson, D. A. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0292 · Cited by 54 · cited 1×
“overweightwomenwho crave carbohydrates [27]; and, to improve cognitive inhibition in adults with mild cognitive impairment [28].”
Cited by
Meta-analysis of the efficacy of psychological and medical treatments for binge-eating disorder
Hilbert, A., Petroff, D., Herpertz, S., Pietrowsky, R., Tuschen-Caffier, B., Vocks, S., & Schmidt, R. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000358 · Cited by 283
Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis
Brownley, K. A., Berkman, N. D., Peat, C. M., Lohr, K. N., Cullen, K. E., Bann, C. M., & Bulik, C. M. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2455 · Cited by 285
Self-citationGhaderi, A., Odeberg, J., Gustafsson, S., Råstam, M., Brolund, A., Pettersson, A., & Parling, T. (2018) · PeerJ · doi:10.7717/peerj.5113 · Cited by 79
Pharmacological approaches to the management of binge eating disorder
Brownley, K. A., Peat, C. M., La Via, M., & Bulik, C. M. (2015) · Drugs · doi:10.1007/s40265-014-0327-0 · Cited by 78
Self-citationCurrent and emerging drug treatments for binge eating disorder
Reas, D. L., & Grilo, C. M. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.879291 · Cited by 52
“(2013) [59] Armodafinil 1 Ongoing clinical trial #NCT01010789** The studies by Ricca et al.”
Metadata
- Authors
- Brownley, K. A., Von Holle, A., Hamer, R. M., La Via, M., & Bulik, C. M.
- Venue
- Journal of Psychosomatic Research
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 75
- Issue
- 1
- Pages
- 36-42
- ISSN
- 0022-3999 (ISSN-L)
- OpenAlex
- W1964519313
- Cited by
- 38
- References
- 7
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: Results of the Binge Eating and Chromium (BEACh) Study. https://app.cochat.ai/papers/10.1016/j.jpsychores.2013.03.092
- The paper
- Brownley, K. A., Von Holle, A., Hamer, R. M., La Via, M., & Bulik, C. M. (2013). A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: Results of the Binge Eating and Chromium (BEACh) Study. Journal of Psychosomatic Research. https://doi.org/10.1016/j.jpsychores.2013.03.092
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.